Scholars Central

Conference abstractPublished 23 Nov 2012

Complimentary approaches to metabolic syndrome: Opportunities and challenges

Authors: Ginpreet Kaur

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Metabolic syndrome has become a worldwide health problem as it affects more than one third of the population and it sets the stage for catastrophic health problems, such as hyperglycemia, high blood pressure, dyslipidaemia, heart disease, and other age-related diseases. But as a matter of fact, till date in modern medicine there has not been a single drug molecule to mitigate these interrelated states of multiple disorders. Although Diet, exercise, and nutritional supplementation play a key role in its prevention and treatment but it is difficult for patients to follow a diet/exercise regime that would improve their symptoms therefore natural products identified from traditional medicinal plants present an exciting opportunity for the treatment of metabolic syndrome because they contain a wide range of phytochemicals with diverse metabolic effects. We have discovered following plants which were found to be of significant importance such as Lagenaria siceraria with Trigonella foenum graecum for hyperlipidemia, Curcuma longa with piper nigrum and Allium cepa in the treatment of glucose tolerance associated with excess dietary fat intake, obesity and type 2 diabetes due to better safety, tolerability and increased healthcare costs with conventional pharmaceuticals. Globally,, with the advancement of modern medicine there has been a tremendous shift in expanding the horizons of availability of medications from traditional herbs as it has significant potential to deliver next generation medicines for metabolic syndrome with the ultimate goal of maximizing the opportunities and overcoming the challenges.

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Similar by topic

More from this journal

The newest in Pharmaceutical Regulatory Affairs: Open Access.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalPharmaceutical Regulatory Affairs: Open Access
  • SubjectPharmaceutical Sciences
  • BylineArticles whose byline prints “Ginpreet Kaur”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels